Tagged with EG

Egypt After months of discussion, in December 2017 Egypt’s Parliament approved a new national health insurance law that aims to overcome some of the inherent problems in the current healthcare system and offer better medical services to the public.   We have studied enough, the time for implementation is now! Dr…

Opinion The Foundations for Evidence-Based Policy-Making Act, recently signed into law in the USA, stands to make government data more accessible; thereby allowing researchers, statisticians and others inside and outside of government to make better, and evidenced-based, policy decisions. Carla Smith outlines the scope of the Act and its potential implications…

China Lorena Di Carlo, a Lundbeck veteran, shares her first impressions of her six months as general manager of Lundbeck China, the strategic significance of China to Lundbeck’s global organization, the company’s commitment to patient-centricity, disease awareness and medical education in the area of brain diseases, and her strategic priorities for…

Spain Ian Wilders, managing director of Labo’Life, a Spanish micro-immunotherapy specialist, discusses the company’s history and the importance of regulatory reform in giving them greater market access and shifting the mindset of doctors. Furthermore, he touches on the company’s international strategy and the importance of a personalized care approach.   Our…

China Dr John Yu, co-founder and CEO of CGeneTech, shares the exciting story behind the company’s establishment in 2010; its balanced philosophy on new drug development and the progress of their flagship Cetagliptin, a Dipeptidyl peptidase-4 (DPP-4) inhibitor of diabetes drug in Phase I clinical trials at the moment; the importance…

Korea Shin Poong is one of the oldest pharmaceutical companies in Korea. Established after the Korean War, the company’s original mission was to provide high-quality and affordable generic medicines to the Korean people. Now the company has transitioned into an innovative developer of novel first-in-class therapeutics, including a malaria treatment on…

China Fendy Yanhui Feng, vice president of Eisai Co., Ltd. and president of Eisai China Holdings Ltd. and Eisai China Inc., shares the significant improvements she has made to Eisai’s China Region operations over the past five years across; the affiliate’s exciting launch of LENVIMA® in 2018 and more upcoming launches…

Korea Cure Therapeutics is a startup developing gene and cell therapies in Korea. Its founder David Kim explains where his passion for regenerative therapies stems from, breaks down the main hurdles standing in the way of success and describes how his company’s business model focused on flexibility and development speed through…

Egypt Janet Heckman, managing director for the southern and eastern Mediterranean region at the European Bank for Reconstruction and Development (EBRD), discusses the main areas of investment for the Bank and the crucial role Egypt plays in the region. She shares her views on the attractiveness of the country for foreign…

Egypt Marwa Taher, executive director of the Swiss Egyptian Business Association (SEBA), explains how the association is promoting trade relations between the two countries. She also highlights initiatives of both SEBA and Swiss companies to improve healthcare and the wellbeing of Egyptian citizens.   There is strong initiative from both countries…

Egypt Amir Ghattas, senior director of the MENA cluster at LEO Pharma, highlights how the company is raising awareness for dermatological diseases in Egypt, having adopted a highly patient-centric focus. He also explains how LEO Pharma’s recent acquisitions and internal restructuration has benefitted the regional operations in the MENA cluster.  …

Egypt Rates of tuberculosis (TB) have dropped dramatically in Egypt over the last 30 years, but there is still work to be done, with the country’s Ministry of Health recently announcing a new campaign to combat the prevalence of the disease   Thanks to the rollout of a national anti-TB programme,…